Mobix Labs Registers Resale of 5M Shares From Toxic Kips Financing — 22.9% Dilution

summarizeSummary

Mobix Labs filed an S-1 to register resale of up to 5 million shares issuable to Kips Bay Select under its toxic preferred financing, representing about 22.9% dilution to existing holders.

check_boxKey Events · Financing and Capital Events · MOBX

• 5M Share Resale Registration

  Registers resale of up to 5,000,000 Class A shares issuable to Kips Bay Select upon conversion of 1,000 Series A Preferred shares and 6,000 shares underlying the August 2026 Preferred Warrant.

• 22.9% Dilution Overhang

  The 5,000,000 Offered Securities would represent approximately 22.9% of the 16,847,921 Class A shares outstanding as of August 24, 2026.

• Toxic Conversion Terms

  Preferred shares convert at 82% of the lowest 8-day VWAP with anti-dilution and market-price adjustments, so the share count can grow as the stock price declines.

• Up to $6M Warrant Proceeds

  The company may receive up to $6,000,000 if the August 2026 Preferred Warrant is exercised, for working capital and general corporate purposes.

auto_awesomeAnalysis · MOBX · Manufacturing

This S-1 registers the resale of up to 5,000,000 shares issuable to Kips Bay Select upon conversion of Series A Preferred Stock and exercise of the August 2026 Preferred Warrant. The filing quantifies the overhang: those shares would represent roughly 22.9% of the 16.8 million Class A shares outstanding as of August 24, 2026. The conversion price floats at 82% of the lowest 8-day VWAP, so the actual share count can grow as the stock falls. Against a backdrop of a $16.8M quarterly loss, going-concern doubts, and a stock trading near $1.14, this registration makes a large block of deeply-discounted shares tradable — a material overhang on the stock.